Complaint Handling and Investigation: Linking CAPA, MDR Reporting, Trend Evaluation, and Recall Considerations

Complaint handling programs often sit at the center of multiple quality and regulatory processes, yet many organizations continue to manage complaints, investigations, CAPA activities, MDR evaluations, trending programs, and recall decisions as largely separate functions. In practice, the most significant compliance risks frequently emerge not from the initial complaint itself, but from how information is interpreted, escalated, connected, and acted upon across the quality system. Questions often arise around investigation depth, reportability determinations, recurring complaint trends, CAPA initiation criteria, and when isolated events may indicate broader product or process concerns.

This session examines complaint handling from a lifecycle perspective, focusing on how complaint information drives downstream quality and regulatory decisions. The discussion will explore investigation strategies, escalation pathways, trend evaluation, MDR decision-making, CAPA linkages, and recall considerations. Practical examples will be used to demonstrate how organizations can strengthen decision-making while maintaining consistent, defensible, and risk-based complaint management practices.

| WHY YOU SHOULD ATTEND

Most complaints do not arrive with enough information to make the next decision obvious. Organizations are often forced to determine whether an event represents an isolated occurrence, a reportable event, the beginning of a trend, a potential CAPA trigger, or an issue that may ultimately require broader corrective action. These decisions are rarely made with complete certainty, yet they often shape the entire downstream response.

In many regulatory actions, the concern is not that a complaint was received, but that important signals were missed, trends were recognized too late, investigations remained too narrow, or escalation decisions were delayed. Effective complaint handling depends on connecting information across multiple quality processes and recognizing when a seemingly routine complaint may indicate a larger issue. This session focuses on the judgment and decision-making required to make those determinations consistently and defensibly.

| AREAS COVERED

• Determining When a Complaint Requires Investigation Beyond Initial Assessment
• Distinguishing Isolated Events from Emerging Product or Quality System Issues
• Evaluating Complaint Trends Before They Become Larger Compliance Problems
• Determining When Complaint Information Supports CAPA Initiation
• Making Defensible MDR Reporting Decisions with Incomplete Information
• Escalation Decisions That May Lead to Field Actions or Recall Evaluation
• Documentation and Evidence Supporting Complaint Investigation Conclusions
• Regulatory Expectations for Complaint Handling, Trending, CAPA, and Post-Market Decision-Making

| WHO SHOULD ATTEND

• Quality Assurance (QA)
• Complaint Handling and Post-Market Surveillance Personnel
• Regulatory Affairs
• CAPA and Quality Systems Professionals
• Medical Device and Pharmaceutical Quality Professionals
• Risk Management Teams
• Compliance and Audit Personnel
• Quality and Regulatory Leadership

Course Director: Meredith Crabtree

Meredith Crabtree has over 30 years’ experience in regulated industries, ranging from Blood, Plasma, Tissue, Laboratory, Pharma, Medical Device, Cosmetics, Supplements, and Animal Health. This includes manufacturing, packaging, labelling and distribution operations. Meredith is the owner of MLKC Consulting is s a Quality Consultant specializing in product label reviews, 3rd party inspections, Cleaning Validation, Analytical Methods and Change Control. She also performs regulatory assessments and Quality trainings.